O. Wiklund

1.8k total citations
43 papers, 1.5k citations indexed

About

O. Wiklund is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, O. Wiklund has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Cardiology and Cardiovascular Medicine and 15 papers in Surgery. Recurrent topics in O. Wiklund's work include Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers) and Adipokines, Inflammation, and Metabolic Diseases (10 papers). O. Wiklund is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers) and Adipokines, Inflammation, and Metabolic Diseases (10 papers). O. Wiklund collaborates with scholars based in Sweden, Finland and Venezuela. O. Wiklund's co-authors include Göran Bondjers, Tom Björnheden, Gunnar Fager, Jan Oscarsson, B.‐Å. Bengtsson, S Edén, T. Rosén, Marja‐Riitta Taskinen, Svend Aage Johnsen and H. Mulec and has published in prestigious journals such as Diabetes, The FASEB Journal and European Heart Journal.

In The Last Decade

O. Wiklund

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Wiklund Sweden 22 680 513 464 347 248 43 1.5k
D. J. Betteridge United Kingdom 21 852 1.3× 652 1.3× 692 1.5× 201 0.6× 342 1.4× 67 2.1k
D Pometta Switzerland 21 738 1.1× 560 1.1× 297 0.6× 200 0.6× 212 0.9× 77 1.9k
A.H.M. Smelt Netherlands 23 764 1.1× 819 1.6× 445 1.0× 302 0.9× 125 0.5× 52 1.8k
Graziana Lupattelli Italy 22 346 0.5× 464 0.9× 558 1.2× 265 0.8× 266 1.1× 80 1.5k
Tadashi Suehiro Japan 30 519 0.8× 510 1.0× 340 0.7× 228 0.7× 228 0.9× 92 2.5k
R M Krauss United States 17 716 1.1× 611 1.2× 263 0.6× 143 0.4× 201 0.8× 24 1.2k
Hans Jansen Netherlands 27 1.1k 1.6× 853 1.7× 707 1.5× 277 0.8× 192 0.8× 60 2.0k
Carlo M. Barbagallo Italy 22 503 0.7× 747 1.5× 580 1.3× 181 0.5× 155 0.6× 100 1.6k
Hiroshi Mokuno Japan 25 409 0.6× 576 1.1× 465 1.0× 271 0.8× 162 0.7× 55 1.7k
J.G. Brook Israel 23 480 0.7× 787 1.5× 479 1.0× 191 0.6× 150 0.6× 76 1.7k

Countries citing papers authored by O. Wiklund

Since Specialization
Citations

This map shows the geographic impact of O. Wiklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Wiklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Wiklund more than expected).

Fields of papers citing papers by O. Wiklund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Wiklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Wiklund. The network helps show where O. Wiklund may publish in the future.

Co-authorship network of co-authors of O. Wiklund

This figure shows the co-authorship network connecting the top 25 collaborators of O. Wiklund. A scholar is included among the top collaborators of O. Wiklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Wiklund. O. Wiklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsson, Helén, Marcus Ståhlman, Thomas Larsson, et al.. (2010). LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome. Journal of Internal Medicine. 269(3). 306–321. 16 indexed citations
2.
3.
Leinonen, Eeva, Anne Hiukka, Eva Hurt‐Camejo, et al.. (2004). Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes. Journal of Internal Medicine. 256(2). 119–127. 64 indexed citations
4.
Hulthe, J., Gudmundur Johannsson, O. Wiklund, et al.. (2003). Increased Interleukin‐6 levels in pituitary‐deficient patients are independently related to their carotid intima‐media thickness. Clinical Endocrinology. 59(2). 242–250. 38 indexed citations
5.
Hulthe, J., O. Wiklund, Göran Bondjers, & John Wikstrand. (2000). LDL particle size in relation to intima‐media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia. Journal of Internal Medicine. 248(1). 42–52. 22 indexed citations
6.
7.
Oscarsson, Jan, et al.. (1995). Recombinant human insulin-like growth factor 1 decreases serum lipoprotein(a) concentrations in man. Atherosclerosis. 115. S36–S36. 1 indexed citations
8.
LINDÉN, T., Göran Bondjers, Therese Karlsson, & O. Wiklund. (1994). Serum triglycerides and HDL cholesterol — major predictors of long-term survival after coronary surgery. European Heart Journal. 15(6). 747–752. 24 indexed citations
9.
Mulec, H., Svend Aage Johnsen, O. Wiklund, & S Björck. (1993). Cholesterol: A Renal Risk Factor in Diabetic Nephropathy. American Journal of Kidney Diseases. 22(1). 196–201. 97 indexed citations
10.
11.
Karlson, B. W., Johan Herlitz, Håkan Emanuelsson, et al.. (1991). One-year mortality rate after discharge from hospital in relation to whether or not a confirmed myocardial infarction was developed. International Journal of Cardiology. 32(3). 381–388. 3 indexed citations
12.
Wiklund, O., et al.. (1991). Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty. European Heart Journal. 12(9). 1020–1028. 23 indexed citations
13.
Bondjers, Göran, et al.. (1990). Transfer of lipoproteins from plasma to the cell populations of the normal and atherosclerotic arterial tissue. European Heart Journal. 11(suppl E). 158–167. 12 indexed citations
14.
Wiklund, O., Bo Angelin, Gunnar Fager, et al.. (1990). Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels. Journal of Internal Medicine. 228(3). 241–247. 38 indexed citations
15.
Camejo, G, et al.. (1989). Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum. Atherosclerosis. 79(2-3). 121–128. 19 indexed citations
16.
LINDÉN, T., Göran Bondjers, Germán Camejo, et al.. (1989). Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction. European Journal of Clinical Investigation. 19(1). 38–44. 42 indexed citations
17.
18.
Wiklund, O., Joseph L. Witztum, T E Carew, et al.. (1987). Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. Journal of Lipid Research. 28(9). 1098–1109. 43 indexed citations
19.
Bondjers, Göran, et al.. (1980). Alphalipoprotein cholesterol and arterial cholesterol in human uterine arteries.. PubMed. 8(4). 388–92. 7 indexed citations
20.
Gustafson, A., Bertil Persson, L E Tisell, O. Wiklund, & Ragnar Ohlson. (1977). Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(3). 220–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. J. Betteridge Breakdown of academic impact, for papers by D Pometta Breakdown of academic impact, for papers by A.H.M. Smelt Breakdown of academic impact, for papers by Graziana Lupattelli Breakdown of academic impact, for papers by Tadashi Suehiro Breakdown of academic impact, for papers by R M Krauss Breakdown of academic impact, for papers by Hans Jansen Breakdown of academic impact, for papers by Carlo M. Barbagallo Breakdown of academic impact, for papers by Hiroshi Mokuno Breakdown of academic impact, for papers by J.G. Brook
Rankless by CCL
2026